Alejandro Crespo
10Patents
1h-index
71Co-inventors
49Inventor score
Filing activity: Jan 19, 2012 → Jan 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8933113B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 8 | Active |
| US9840512B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US10208060B2 | Inhibitors of HIF prolyl hydroxylase | Chemistry; Metallurgy | 0 | Active |
| US9969752B2 | Inhibitors of HIF prolyl hydroxylase | Chemistry; Metallurgy | 0 | Active |
| US10287269B2 | Pyrazolyl pyrimidinone compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10000501B2 | Inhibitors of HIF prolyl hydroxylase | Chemistry; Metallurgy | 0 | Active |
| US12344623B2 | Thiazolopyridine derivatives as adenosine receptor antagonists | Emerging Cross-Sectional Technologies | 0 | Active |
| US9403807B2 | Mineralocorticoid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US10138255B2 | Piperazine derivatives as HIV protease inhibitors | Human Necessities | 0 | Active |
| US10358435B2 | Triazolyl pyrimidinone compounds as PDE2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.